Jennifer Majka was appointed Head of Marketing at Neurotech in June 2024. She has over 20 years of commercial leadership experience, specializing in the launch of rare disease therapies and leading franchises and products across all stages of the lifecycle.
In her current role, Jennifer is responsible for leading the company’s launch strategy and ensuring effective customer engagement.
Prior to joining Neurotech, Jennifer held leadership roles including Vice President of Marketing and Vice President, Franchise Head at several global biotechnology companies, both public and private, such as Shire/Takeda, and Allakos.
Jennifer is a member of Ophthalmic World Leaders (OWL) and Women in Bio (WIB).
